• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

西班牙慢性阻塞性肺疾病急性加重导致的住院治疗的实际负担。

Real-life burden of hospitalisations due to COPD exacerbations in Spain.

作者信息

Izquierdo José Luis, Rodríguez José Miguel, Almonacid Carlos, Benavent María, Arroyo-Espliguero Ramón, Agustí Alvar

机构信息

Dept of Medicine and Medical Specialties, University of Alcalá, Alcalá de Henares, Spain.

Respiratory Medicine, University Hospital of Guadalajara, Guadalajara, Spain.

出版信息

ERJ Open Res. 2022 Aug 15;8(3). doi: 10.1183/23120541.00141-2022. eCollection 2022 Jul.

DOI:10.1183/23120541.00141-2022
PMID:35983537
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9379352/
Abstract

BACKGROUND

Patients with chronic obstructive pulmonary disease (COPD) often suffer episodes of exacerbation of symptoms (ECOPD) that may eventually require hospitalisation due to several, often overlapping, causes. We aimed to analyse the characteristics of patients hospitalised because of ECOPD in a real-life setting using a "big data" approach.

METHODS

The study population included all patients over 40 years old with a diagnosis of COPD (n=69 359; prevalence 3.72%) registered from 1 January 2011 to 1 March 2020 in the database of the public healthcare service (SESCAM) of Castilla-La Mancha (Spain) (n=1 863 759 subjects). We used natural language processing (Savana Manager version 3.0) to identify those who were hospitalised during this period for any cause, including ECOPD.

RESULTS

During the study 26 453 COPD patients (38.1%) were hospitalised (at least once). Main diagnoses at discharge were respiratory infection (51%), heart failure (38%) or pneumonia (19%). ECOPD was the main diagnosis at discharge (or hospital death) in 8331 patients (12.0% of the entire COPD population and 31.5% of those hospitalised). In-hospital ECOPD-related mortality rate was 3.11%. These patients were hospitalised 2.36 times per patient, with a mean hospital stay of 6.1 days. Heart failure was the most frequent comorbidity in patients hospitalised because of ECOPD (52.6%).

CONCLUSIONS

This analysis shows that, in a real-life setting, ECOPD hospitalisations are prevalent, complex (particularly in relation to heart failure), repetitive and associated with significant in-hospital mortality.

摘要

背景

慢性阻塞性肺疾病(COPD)患者经常出现症状加重发作(ECOPD),由于多种往往相互重叠的原因,最终可能需要住院治疗。我们旨在采用“大数据”方法分析在现实环境中因ECOPD住院的患者特征。

方法

研究人群包括2011年1月1日至2020年3月1日在西班牙卡斯蒂利亚 - 拉曼恰公共医疗服务数据库(SESCAM)中登记的所有40岁以上诊断为COPD的患者(n = 69359;患病率3.72%)(n = 1863759名受试者)。我们使用自然语言处理(Savana Manager 3.0版)来识别在此期间因任何原因住院的患者,包括ECOPD。

结果

在研究期间,26453名COPD患者(38.1%)至少住院一次。出院时的主要诊断为呼吸道感染(51%)、心力衰竭(38%)或肺炎(19%)。ECOPD是8331名患者出院时(或医院死亡时)的主要诊断(占整个COPD人群的12.0%,占住院患者的31.5%)。住院期间ECOPD相关死亡率为3.11%。这些患者每人住院2.36次,平均住院时间为6.1天。心力衰竭是因ECOPD住院患者中最常见的合并症(52.6%)。

结论

该分析表明,在现实环境中,ECOPD住院很普遍、情况复杂(尤其是与心力衰竭相关)、具有重复性且与显著的住院死亡率相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c15/9379352/9a9692083b4b/00141-2022.01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c15/9379352/9a9692083b4b/00141-2022.01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c15/9379352/9a9692083b4b/00141-2022.01.jpg

相似文献

1
Real-life burden of hospitalisations due to COPD exacerbations in Spain.西班牙慢性阻塞性肺疾病急性加重导致的住院治疗的实际负担。
ERJ Open Res. 2022 Aug 15;8(3). doi: 10.1183/23120541.00141-2022. eCollection 2022 Jul.
2
Chronic obstructive pulmonary disease exacerbation fundamentals: Diagnosis, treatment, prevention and disease impact.慢性阻塞性肺疾病恶化基础:诊断、治疗、预防和疾病影响。
Respirology. 2021 Jun;26(6):532-551. doi: 10.1111/resp.14041. Epub 2021 Apr 24.
3
Circulating eosinophil levels do not predict severe exacerbations in COPD: a retrospective study.循环嗜酸性粒细胞水平不能预测慢性阻塞性肺疾病的严重加重:一项回顾性研究。
ERJ Open Res. 2018 Aug 3;4(3). doi: 10.1183/23120541.00022-2018. eCollection 2018 Jul.
4
Global mortality and readmission rates following COPD exacerbation-related hospitalisation: a meta-analysis of 65 945 individual patients.慢性阻塞性肺疾病加重相关住院后的全球死亡率和再入院率:对65945例个体患者的荟萃分析
ERJ Open Res. 2024 Feb 26;10(1). doi: 10.1183/23120541.00838-2023. eCollection 2024 Jan.
5
Application of the Rome severity classification of COPD exacerbations in a real-world cohort of hospitalised patients.慢性阻塞性肺疾病急性加重的罗马严重程度分类在住院患者真实队列中的应用。
ERJ Open Res. 2023 May 15;9(3). doi: 10.1183/23120541.00569-2022. eCollection 2023 May.
6
Subtypes of patients experiencing exacerbations of COPD and associations with outcomes.COPD 加重患者的亚型及与结局的关系。
PLoS One. 2014 Jun 3;9(6):e98580. doi: 10.1371/journal.pone.0098580. eCollection 2014.
7
Multi-level differential network analysis of COPD exacerbations.多水平差异网络分析在 COPD 加重中的应用。
Eur Respir J. 2017 Sep 27;50(3). doi: 10.1183/13993003.00075-2017. Print 2017 Sep.
8
Hospitalizations due to exacerbations of COPD: A big data perspective.因 COPD 恶化导致的住院治疗:大数据视角。
Respir Med. 2018 Dec;145:219-225. doi: 10.1016/j.rmed.2018.01.008. Epub 2018 Jan 16.
9
Pneumonia as comorbidity in chronic obstructive pulmonary disease (COPD). Differences between acute exacerbation of COPD and pneumonia in patients with COPD.肺炎作为慢性阻塞性肺疾病(COPD)的合并症。COPD患者中COPD急性加重与肺炎的差异。
Arch Bronconeumol. 2014 Dec;50(12):514-20. doi: 10.1016/j.arbres.2014.02.001. Epub 2014 Oct 25.
10
Balance and Falls in Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Prospective Study.慢性阻塞性肺疾病急性加重期的平衡和跌倒:一项前瞻性研究。
COPD. 2017 Oct;14(5):518-525. doi: 10.1080/15412555.2017.1342232. Epub 2017 Jul 26.

引用本文的文献

1
Vaccination Strategies in Respiratory Diseases: Recommendation from AIPO-ITS/ETS, SIMIT, SIP/IRS, and SItI.呼吸系统疾病的疫苗接种策略:来自AIPO-ITS/ETS、SIMIT、SIP/IRS和SItI的建议。
Respiration. 2025;104(8):556-574. doi: 10.1159/000544919. Epub 2025 Mar 9.
2
The Clinical Profile of Patients with COPD Is Conditioned by Age.慢性阻塞性肺疾病患者的临床特征受年龄影响。
J Clin Med. 2023 Dec 9;12(24):7595. doi: 10.3390/jcm12247595.
3
The impact of the SARS-CoV-2 pandemic on the demographic, clinical and social profiles of patients admitted to the Pneumology Department for a COPD exacerbation.

本文引用的文献

1
Treatment Trials in Young Patients with Chronic Obstructive Pulmonary Disease and Pre-Chronic Obstructive Pulmonary Disease Patients: Time to Move Forward.慢性阻塞性肺疾病和慢性阻塞性肺疾病前患者的青年患者治疗试验:是时候向前推进了。
Am J Respir Crit Care Med. 2022 Feb 1;205(3):275-287. doi: 10.1164/rccm.202107-1663SO.
2
An Updated Definition and Severity Classification of Chronic Obstructive Pulmonary Disease Exacerbations: The Rome Proposal.慢性阻塞性肺疾病急性加重的更新定义与严重程度分类:罗马提议
Am J Respir Crit Care Med. 2021 Dec 1;204(11):1251-1258. doi: 10.1164/rccm.202108-1819PP.
3
Assessing the Performance of Clinical Natural Language Processing Systems: Development of an Evaluation Methodology.
SARS-CoV-2 大流行对因 COPD 加重而入住肺病科患者的人口统计学、临床和社会特征的影响。
PLoS One. 2023 Sep 14;18(9):e0290156. doi: 10.1371/journal.pone.0290156. eCollection 2023.
评估临床自然语言处理系统的性能:一种评估方法的开发
JMIR Med Inform. 2021 Jul 23;9(7):e20492. doi: 10.2196/20492.
4
The impact of COVID-19 on patients with asthma.COVID-19 对哮喘患者的影响。
Eur Respir J. 2021 Mar 4;57(3). doi: 10.1183/13993003.03142-2020. Print 2021 Mar.
5
Impacts of Comorbid Chronic Obstructive Pulmonary Disease and Congestive Heart Failure on Prognosis of Critically Ill Patients.合并慢性阻塞性肺疾病和充血性心力衰竭对危重症患者预后的影响。
Int J Chron Obstruct Pulmon Dis. 2020 Oct 28;15:2707-2714. doi: 10.2147/COPD.S275573. eCollection 2020.
6
Characteristics and Prognosis of COVID-19 in Patients with COPD.慢性阻塞性肺疾病患者感染新型冠状病毒肺炎的特征及预后
J Clin Med. 2020 Oct 12;9(10):3259. doi: 10.3390/jcm9103259.
7
Accelerated FEV decline and risk of cardiovascular disease and mortality in a primary care population of COPD patients.慢性阻塞性肺疾病(COPD)初级保健人群中用力呼气量(FEV)加速下降与心血管疾病及死亡风险
Eur Respir J. 2021 Mar 4;57(3). doi: 10.1183/13993003.00918-2020. Print 2021 Mar.
8
Prevalence and Determinants of COPD in Spain: EPISCAN II.西班牙慢性阻塞性肺疾病的患病率及决定因素:EPISCAN II研究
Arch Bronconeumol (Engl Ed). 2021 Jan;57(1):61-69. doi: 10.1016/j.arbres.2020.07.024. Epub 2020 Sep 17.
9
Time for a change: anticipating the diagnosis and treatment of COPD.是时候做出改变了:预测慢性阻塞性肺疾病的诊断与治疗。
Eur Respir J. 2020 Jul 30;56(1). doi: 10.1183/13993003.02104-2020. Print 2020 Jul.
10
Clinical Management of COPD in a Real-World Setting. A Big Data Analysis.真实世界中 COPD 的临床管理。大数据分析。
Arch Bronconeumol (Engl Ed). 2021 Feb;57(2):94-100. doi: 10.1016/j.arbres.2019.12.025. Epub 2020 Feb 22.